Literature DB >> 17302872

Implications of resistin plasma levels in subjects undergoing coronary angiography.

Stefan Pilz1, Gisela Weihrauch, Ursula Seelhorst, Britta Wellnitz, Bernhard R Winkelmann, Bernhard O Boehm, Winfried März.   

Abstract

BACKGROUND: The adipokine resistin, which is thought to serve as a link between obesity and insulin resistance, was recently shown to exert proatherosclerotic features.
OBJECTIVE: Our study aimed to explore the involvement of resistin in cardiovascular disease by investigating the associations of resistin with angiographic coronary artery disease (CAD), cardiovascular risk factors and mortality.
DESIGN: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study is a prospective study of white subjects who had undergone coronary angiography. PATIENTS AND MEASUREMENTS: Resistin levels were determined in 1162 subjects with (n = 911) and without (n = 251) angiographic CAD. During a mean follow-up period of 5.47 years, 198 deaths occurred among our probands.
RESULTS: Resistin was positively correlated with C-reactive protein (CRP; r = 0.245, P < 0.001), vascular adhesion molecule-1 (VCAM-1; r = 0.327, P < 0.001) and intercellular adhesion molecule-1 (ICAM-1; r = 0.197, P < 0.001) and was negatively correlated with glomerular filtration rate (GFR; r = -0.438, P < 0.001) and high density lipoprotein (HDL; r = -0.196, P < 0.001). Multiple regression analysis revealed that GFR was the strongest predictive variable for resistin. Angiographic CAD, type 2 diabetes, smoking, hypertension and body mass index (BMI) were not associated with resistin. Compared to the first quartile, we observed an increased risk for cardiovascular and noncardiovascular mortality at the fourth quartile of resistin, but only the association between resistin and noncardiovascular mortality remained significant after multivariable adjustments [hazard ratio (HR) 4.92, 95% confidence interval (CI) 1.66-14.6, P = 0.004].
CONCLUSIONS: Resistin plasma concentrations are related to inflammatory processes and renal function but our study does not support the hypothesis of resistin as an independent cardiovascular risk factor. The unexpected association of resistin with noncardiovascular mortality still warrants further study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17302872     DOI: 10.1111/j.1365-2265.2007.02743.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  16 in total

Review 1.  Adipose tissue and vascular inflammation in coronary artery disease.

Authors:  Enrica Golia; Giuseppe Limongelli; Francesco Natale; Fabio Fimiani; Valeria Maddaloni; Pina Elvira Russo; Lucia Riegler; Renatomaria Bianchi; Mario Crisci; Gaetano Di Palma; Paolo Golino; Maria Giovanna Russo; Raffaele Calabrò; Paolo Calabrò
Journal:  World J Cardiol       Date:  2014-07-26

2.  Correlates of resistin in children with chronic kidney disease: the chronic kidney disease in children cohort.

Authors:  Edward Nehus; Susan Furth; Bradley Warady; Mark Mitsnefes
Journal:  J Pediatr       Date:  2012-03-14       Impact factor: 4.406

3.  Impact of uremia on human adipose tissue phenotype.

Authors:  Karen J Ho; Hui Xue; Christine R Mauro; Binh Nguyen; Peng Yu; Ming Tao; Michael A Seidman; Steven M Brunelli; Charles Keith Ozaki
Journal:  J Surg Res       Date:  2012-09-06       Impact factor: 2.192

4.  Endogenous adipose-derived factors diminish coronary endothelial function via inhibition of nitric oxide synthase.

Authors:  Gregory A Payne; Léna Borbouse; Ian N Bratz; William C Roell; H Glenn Bohlen; Gregory M Dick; Johnathan D Tune
Journal:  Microcirculation       Date:  2008-07       Impact factor: 2.628

5.  Circulating resistin protein and mRNA concentrations and clinical severity of coronary artery disease.

Authors:  Jelena Joksic; Miron Sopic; Vesna Spasojevic-Kalimanovska; Dimitra Kalimanovska-Ostric; Kristina Andjelkovic; Zorana Jelic-Ivanovic
Journal:  Biochem Med (Zagreb)       Date:  2015-06-05       Impact factor: 2.313

6.  Resistin in rodents and humans.

Authors:  Hyeong Kyu Park; Rexford S Ahima
Journal:  Diabetes Metab J       Date:  2013-12       Impact factor: 5.376

7.  Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study.

Authors:  Haruhiko Osawa; Yasufumi Doi; Hideichi Makino; Toshiharu Ninomiya; Koji Yonemoto; Ryoichi Kawamura; Jun Hata; Yumihiro Tanizaki; Mitsuo Iida; Yutaka Kiyohara
Journal:  Cardiovasc Diabetol       Date:  2009-11-18       Impact factor: 9.951

8.  Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes.

Authors:  Claudia Menzaghi; Simonetta Bacci; Lucia Salvemini; Christine Mendonca; Giuseppe Palladino; Andrea Fontana; Concetta De Bonis; Antonella Marucci; Elizabeth Goheen; Sabrina Prudente; Eleonora Morini; Stefano Rizza; Alyssa Kanagaki; Grazia Fini; Davide Mangiacotti; Massimo Federici; Salvatore De Cosmo; Fabio Pellegrini; Alessandro Doria; Vincenzo Trischitta
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

9.  Resistin levels in perivascular adipose tissue and mid-term mortality in patients undergoing coronary artery bypass grafting.

Authors:  M Rachwalik; M Obremska; D Zyśko; M Matusiewicz; M Protasiewicz; M Jasiński
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

10.  Resistin competes with lipopolysaccharide for binding to toll-like receptor 4.

Authors:  Andrej Tarkowski; Jan Bjersing; Andrey Shestakov; Maria I Bokarewa
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.